0001493152-23-042658.txt : 20231124
0001493152-23-042658.hdr.sgml : 20231124
20231124160005
ACCESSION NUMBER: 0001493152-23-042658
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231121
FILED AS OF DATE: 20231124
DATE AS OF CHANGE: 20231124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wei Binxian
CENTRAL INDEX KEY: 0001773586
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33672
FILM NUMBER: 231436698
MAIL ADDRESS:
STREET 1: P.O. BOX 2231
CITY: LIVINGSTON
STATE: NJ
ZIP: 07039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PALISADE BIO, INC.
CENTRAL INDEX KEY: 0001357459
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 522007292
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7750 EL CAMINO REAL, SUITE 5200
CITY: CARLSBAD
STATE: CA
ZIP: 92009
BUSINESS PHONE: (858) 704-4900
MAIL ADDRESS:
STREET 1: 7750 EL CAMINO REAL, SUITE 5200
CITY: CARLSBAD
STATE: CA
ZIP: 92009
FORMER COMPANY:
FORMER CONFORMED NAME: Seneca Biopharma, Inc.
DATE OF NAME CHANGE: 20200127
FORMER COMPANY:
FORMER CONFORMED NAME: Neuralstem, Inc.
DATE OF NAME CHANGE: 20060324
4
1
ownership.xml
X0508
4
2023-11-21
0
0001357459
PALISADE BIO, INC.
PALI
0001773586
Wei Binxian
7750 EL CAMINO REAL, SUITE 2A
CARLSBAD,
CA
92009
1
0
0
0
0
Restricted Stock Units
2023-11-21
4
A
0
5820
0.00
A
Common Stock
5820
5820
D
Common Stock Options
0.59
2023-11-21
4
A
0
6880
0.00
A
2033-11-21
Common Stock
6880
6880
D
Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee.
The grants vest fully on the one (1) year anniversary of the grant date.
Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
N/A.
Each option represents the right to purchase one share of common stock at the exercise price.
/s/ Binxian Wei
2023-11-24